Licensed for intrathecal use
Products licensed for intrathecal use are the first line option and should be used wherever suitable.
There are currently no known clonidine products licensed for intrathecal administration.
Not licensed for intrathecal use, limited information available
Products with partial information that are not licensed for intrathecal administration can still sometimes be used. Refer to the advice in our article and complete a risk assessment to enable you to interpret the details below and choose an appropriate product.
Glenwood (Catapres®)
Strength
Excipients
Sodium chloride, 1N hydrochloric acid, water for injection
Osmolarity
237 – 301 mOsmol/kg (undiluted)
pH
4 – 6 (undiluted)
Endotoxin content
No information
Unlicensed ‘Special’, specified for intrathecal use
Unlicensed medicines that are manufactured in MHRA-licensed Specials Manufacturing Units, at the request of an authorised healthcare professional specifically for intrathecal use.
St Mary’s Pharmaceutical Unit, Cardiff
Strength
2mg/mL in 10mL vials